The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Radiation Oncology
Volume 15 - 2025 |
doi: 10.3389/fonc.2025.1511260
Predicting Microvascular Invasion in Solitary Hepatocellular Carcinoma: A Multi-Center Study Integrating Clinical, MRI assessments, and Radiomics Indicators
Provisionally accepted- 1 Department of ultrasound, Mengchao hepatobiliary hospital of Fujian medical university, Fuzhou, China, Fuzhou, Fujian Province, China
- 2 Department of radiology Mengchao hepatobiliary hospital of Fujian medical university, Fuzhou, Fujian Province, China
- 3 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian Province, China
- 4 Mengchao Hepatobiliary Hospital, Fuzhou, Fujian Province, China
- 5 Department of Radiology,Datian County General Hospital, Sanming, China
- 6 Department of Radiology, Second Hospital of Nanping City,, Nanping, China
Abstract Background: Microvascular invasion (MVI) is a key prognostic factor in solitary hepatocellular carcinoma (HCC), significantly affecting treatment decisions and outcomes. Early prediction of MVI is crucial for enhancing clinical decision-making. Objectives: This study aimed to develop and evaluate four predictive models for MVI: one based on clinical indicators, one on MRI assessments, one using radiomics, and a combined model integrating all data across multiple medical centers. Methods: The study included patients with solitary HCC from three centers (Mengchao Hepatobiliary Hospital, The Second Hospital of Nanping, and Datian County General Hospital). The dataset was divided into an internal training set, validation set, and two external validation sets. Predictive models were built using clinical indicators, MRI, radiomics, and a combination of these. Model performance was assessed through ROC curves, calibration curves, and decision curve analysis (DCA). Lasso regression identified significant features, and SHAP analysis interpreted the model predictions. Results: A total of 319 patients were analyzed: 199 from the internal center, 67 from Nanping, and 53 from Datian. The combined model, which integrated clinical, MRI, and radiomics features, showed superior performance, with an AUC of 0.95(95%CI:0.92-0.98) in the internal training set, 0.92(95%CI:0.83-1.00) in the internal validation set, 0.96(95%CI:0.92-1.00) in Nanping, and 0.94(95%CI:0.88-0.99) in Datian. Calibration curves confirmed the model's accuracy, and NRI/IDI analyses highlighted its advantage over individual models. Key predictive indicators included pseudocapsule, peritumoral enhancement, and wavelet-based MRI features. Conclusion: This multi-center study demonstrates the effectiveness of combining clinical, MRI, and radiomics data in predicting MVI in solitary HCC, with robust results across different medical centers. These models have potential to improve patient management and treatment planning
Keywords: Microvascular invasion (MVI), Radiomics, MRI, multi-center study, Predictive Modeling
Received: 14 Oct 2024; Accepted: 03 Jan 2025.
Copyright: © 2025 Tu, Wang, Zhan, Lin, Yang, Yu, Xie, Lin and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Haibin Tu, Department of ultrasound, Mengchao hepatobiliary hospital of Fujian medical university, Fuzhou, China, Fuzhou, Fujian Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.